Compounds > ci 988
Page last updated: 2024-09-02

ci 988 and boc-tyr(s03)-nle-gly-trp-nle-asp-2-phenylethyl ester

ci 988 has been researched along with boc-tyr(s03)-nle-gly-trp-nle-asp-2-phenylethyl ester in 1 studies

Compound Research Comparison

Studies
(ci 988)		Trials
(ci 988)		Recent Studies (post-2010)
(ci 988)		Studies
(boc-tyr(s03)-nle-gly-trp-nle-asp-2-phenylethyl ester)		Trials
(boc-tyr(s03)-nle-gly-trp-nle-asp-2-phenylethyl ester)		Recent Studies (post-2010) (boc-tyr(s03)-nle-gly-trp-nle-asp-2-phenylethyl ester)
1478147703

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ohtsuka, T; Yokose, K1

Reviews

1 review(s) available for ci 988 and boc-tyr(s03)-nle-gly-trp-nle-asp-2-phenylethyl ester

ArticleYear
[Cholecystokinin receptor antagonists].
    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 1993, Volume: 38, Issue:11

    Topics: Amino Acid Sequence; Animals; Benzodiazepinones; Cholecystokinin; Furans; Indoles; Meglumine; Molecular Sequence Data; Proglumide; Receptors, Cholecystokinin; Sincalide; Thiophenes

1993